In most CML patients and approximately one-quarter of Ph chromosome-positive (Ph + ) ALL patients, exon 13 or 14 of the BCR gene is fused to exon 2 of the ABL1 gene, which encodes p210 BCR::ABL1 fusion protein [6]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.